13F

Stock

Phathom Pharmaceuticals, Inc.

PHAT · held by 7 managers

Reported value

$8.89M

Holders

7

+1 new · −0 exited

Holders’ est. mark

$179.1K

Price effect on 1 books still in the name

Largest holder

$3.01M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY255.6K$3.01MHeld
BANK OF AMERICA CORP /DE/249.1K$2.93MHeld
BARCLAYS PLC128.4K$1.51M$179.1KAdded$722.7K
Penn Mutual Asset Management62.8K$739.2KHeld
TUDOR INVESTMENT CORP ET AL34.1K$401.2KHeld
Allworth Financial LP20.4K$240.7KHeld
Leonteq Securities AG4.8K$56.5KNew

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.